IP Library Patent Application 14723415
Patent Application
App. No. 14/723,415

APPARATUS AND METHODS FOR INTRAVENOUS GAS ELIMINATION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/723,415
Abstract

A gas elimination apparatus and a method for use in an intravenous delivery system are provided. The apparatus includes a fluid inlet coupling a fluid flow into a liquid chamber, a fluid outlet protruding into the liquid chamber, and a flow diversion member proximal to the fluid outlet. The flow diversion member configured to block a direct flow between the fluid inlet and the fluid outlet. The apparatus includes a hydrophobic membrane separating a portion of the liquid chamber from an outer chamber and a gas venting valve fluidically coupling the outer chamber with the atmosphere.

Claims (42)

1 . A gas elimination apparatus for use in an intravenous (IV) delivery system, comprising:

a fluid inlet coupling a fluid flow into a liquid chamber;

a fluid outlet protruding into the liquid chamber;

a flow diversion member proximal to the fluid outlet, the flow diversion member configured to block a direct flow between the fluid inlet and the fluid outlet;

a hydrophobic membrane separating a portion of the liquid chamber from an outer chamber; and

a gas venting valve fluidically coupling the outer chamber with the atmosphere.

2 . The apparatus of claim 1 , wherein the hydrophobic membrane comprises protrusions contacting a wall of the outer chamber to provide structural support to the hydrophobic membrane.

3 . The apparatus of claim 2 , wherein the hydrophobic membrane comprises depressions intersecting the protrusions to provide a flow continuity to the outer chamber.

4 . The apparatus of claim 2 , wherein the protrusions are parallel to a longitudinal axis of the liquid chamber or perpendicular to the longitudinal axis of the liquid chamber.

5 . The apparatus of claim 1 , wherein a wall of the outer chamber comprises protrusions that contact the hydrophobic membrane to provide structural support to the hydrophobic membrane.

6 . The apparatus of claim 5 , wherein the protrusions are parallel to a longitudinal axis of the liquid chamber or perpendicular to a longitudinal axis of the liquid chamber.

7 . The apparatus of claim 1 , wherein the liquid chamber comprises a cylindrical shape with a longitudinal axis aligned with the fluid inlet and the fluid outlet, and the hydrophobic membrane comprises a first hydrophobic membrane along the curved cylindrical surface and a second hydrophobic membrane along at least one of the two flat surfaces of the cylinder.

8 . The apparatus of claim 1 , wherein the liquid chamber comprises a non-cylindrical shape with a polygonal cross-section perpendicular to a longitudinal axis, wherein the polygonal cross-section is one of a triangular, rectangular, pentagonal, hexagonal, heptagonal, octagonal, or a higher edge-number polygonal shape, and the fluid inlet and fluid outlet are aligned along the longitudinal axis.

9 . The apparatus of claim 1 , wherein the flow diversion member allows a blood component other than a gas bubble to reach the fluid outlet, wherein the blood component comprises at least one of a red blood cell or an undissolved solid in blood.

10 . The apparatus of claim 1 , wherein the flow diversion member is disposed on one or more struts which are hydrofoils.

11 . The apparatus of claim 1 , wherein the gas venting valve is configured to open when a pressure in the outer chamber reaches a preselected value, the preselected value being approximately equal to the atmospheric pressure of a room in a healthcare facility where the apparatus is located.

12 . A gas elimination apparatus for use in intravenous delivery system, comprising:

a fluid inlet coupling a fluid flow into a liquid conduit, the liquid conduit concentric with a hollow chamber along a longitudinal axis, wherein the hollow chamber is separated from the liquid conduit by a hydrophobic membrane;

a fluid outlet fluidically coupled with the liquid conduit;

an outer chamber concentric with the liquid conduit and separated from the liquid conduit by a hydrophobic membrane;

a center hub fluidically coupling the hollow chamber and the outer chamber; and

a gas venting valve fluidically coupling the outer chamber and the atmosphere.

13 . The apparatus of claim 12 , further comprising a first support and a second support on either end of the hollow chamber, the first support and the second support blocking the fluid flow through the hollow chamber and allowing a fluid flow from the fluid inlet to the fluid outlet through the liquid conduit.

14 . The apparatus of claim 12 , wherein the center hub is supported on a wall of the outer chamber through radial spokes, the radial spokes having a hollow conduit fluidically coupling the hollow chamber with the outer chamber.

15 . An intravenous (IV) delivery system, comprising:

a container including an intravenous liquid;

a mechanism to provide a pressure to move the intravenous liquid through a fluid line to a patient; and

a gas elimination apparatus fluidically coupled with the fluid line, and configured to remove gas bubbles from the intravenous liquid, wherein the gas elimination apparatus comprises:

a flow diversion member configured to block a direct flow between a fluid inlet and a fluid outlet;

a hydrophobic membrane separating a portion of fluid from an outer chamber; and

a gas venting valve fluidically coupling the outer chamber and the atmosphere.

16 . The system of claim 15 , wherein the mechanism to provide a pressure comprises one of a pump, or a frame to place the liquid container at a higher elevation relative to the patient.

17 . The system of claim 15 , further comprising an antenna configured to receive commands and transmit data to a controller comprising a processor and a memory, the memory storing instructions that when executed by the processor cause the controller to send the commands to the IV delivery system and receive the data from the IV delivery system.

18 . A method, comprising:

receiving a fluid flow through a fluid inlet of a gas elimination apparatus;

placing the fluid flow in contact with a hydrophobic membrane separating a liquid chamber and an outer chamber in the gas elimination apparatus;

allowing a gas bubble in the fluid flow to transition through the hydrophobic membrane into the outer chamber;

opening a valve in the outer chamber to vent gas into the atmosphere; and

delivering the fluid flow through a fluid outlet of the gas elimination apparatus.

19 . The method of claim 18 , further comprising diverting the fluid flow in the proximity of the fluid outlet prior to placing the fluid flow in contact with the hydrophobic membrane.

20 . The method of claim 18 , wherein allowing the gas bubble in the fluid flow to transition through the hydrophobic membrane into the outer chamber comprises adjusting a fluid flow rate so that the time it takes for the bubble to travel from the fluid inlet to the hydrophobic membrane is less than the time it takes for the bubble to travel from the fluid inlet to the fluid outlet.

21 . The method of claim 20 , wherein adjusting the fluid flow rate comprises increasing a pump rate for the fluid according to a sensor reading, the sensor reading associated with a bubble count downstream from the gas elimination apparatus.

Assignments (6)
PARTIAL TERMINATION AND RELEASE OF SECURITY INTEREST RECORDED AT 0459686/0050, 4/18/2018. Recorded May 3, 2023
From: BANK OF AMERICA, N.A.
To: VITAL SIGNS, INC.
Reel/Frame 063528/0805 →
FIRST LIEN SECURITY AGREEMENT Recorded Apr 18, 2018
From: VITAL SIGNS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 045968/0050 →
SECOND LIEN SECURITY AGREEMENT Recorded Apr 18, 2018
From: VITAL SIGNS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 045969/0596 →
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2018
From: CITIZENS BANK, N.A.
To: VYAIRE MEDICAL CAPITAL LLC; VYAIRE MEDICAL CONSUMABLES LLC; CAREFUSION 202, INC.; VITAL SIGNS, INC.
Reel/Frame 045779/0035 →
SECURITY AGREEMENT Recorded Oct 14, 2016
From: VYAIRE MEDICAL CAPITAL LLC; VYAIRE MEDICAL CONSUMABLES LLC; VITAL SIGNS, INC.; CAREFUSION 202, INC.
To: CITIZENS BANK, N.A, AS COLLATERAL AGENT
Reel/Frame 040357/0952 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2015
From: MOHR, JASON ANTHONY; VARGA, CHRISTOPHER; RETZLAFF, NATHAN
To: VITAL SIGNS, INC.
Reel/Frame 035732/0809 →